Skip to Content

Urogynecology

Treatment for Recurrent Urinary Tract Infections and its Effect on the Urinary Microbiota and Mycobiota in Post-Menopausal Women
Aims: The purpose of this study is to investigate the relationship between oral antibiotics and the urinary bacteria of patients with recurrent urinary tract infections (UTIs). We want to enroll these women before they begin their antibiotic regimen.
Diagnosis: Post-menopausal status based on history (no menses within 1 year), at least 2 culture positive UTIs within the past 6 months or 3 within the past year
Principal Investigator: Sonia Dutta, MD
Co-Investigator(s): Joseph Pincus, MD
IRB Approval Number: EH19-300
Sponsor: NorthShore
Contact: Interested patients should call 224.251.3492
Open to Enrollment: Yes

Interstitial Cystitis Pain Improvement with Naltrexone: The Effect of Low-Dose Naltrexone on Symptoms and Pain of Patients with Interstitial Cystitis/Painful Bladder Syndrome: A Randomized Placebo-Controlled Prospective Trial (IC PaIN)
Aims: This study aims to determine the effect of using low-dose naltrexone (LDN) on symptoms of patients diagnosed with interstitial cystitis/painful bladder syndrome (IC/PBS). The purpose of this study is to determine whether there is a significant decrease in IC symptoms and pain when treating IC/PBS with LDN.
Diagnosis: Women 18 years and older, newly diagnosed with IC/PBS and have not yet received treatment with medication
Principal Investigator: Nani Moss, MD
IRB Approval Number: EH20-127
Sponsor: NorthShore
Contact: Interested patients should call 224.251.3492
Open to Enrollment: Yes

The Effect of Mid-Urethral Sling on the Urethral Dynamic Shape and Motion
Aims: The purpose of this prospective cohort study is to investigate the effect of a sling on urethral dynamic shape and motion using static and dynamic pelvic floor ultrasound, and to compare findings among women with successful vs. failed surgical outcomes.
Diagnosis: Women 18 years and older with stress urinary incontinence, deciding to proceed with surgical treatment
Principal Investigator: Joel Winer, MD
IRB Approval Number: EH21-027
Sponsor: NorthShore
Contact: Interested patients should call 224.251.3492
Open to Enrollment: Yes

Mesh-free Suture Urethropexy for Treating Stress Urinary Incontinence Efficacy and Durability Trial
Aims: This study aims to evaluate the effecitveness of minimally invasive, mesh-free surgical treatment for stress urinary incontinence.
Diagnosis: Women ages 18 and older who have stress urinary incontinence and are planning to have mid-urethral sling surgery
Principal Investigator: Ghazaleh Rostami Nia, MD
IRB Approval Number: EH21-062
Sponsor: NorthShore
Contact: Interested patients should call 224.251.3492
Open to Enrollment: Yes

A Prospective Study to Assess the Efficacy and Safety of the BlueWind RENOVA iStim System for the Treatment of Patients Diagnosed with Overactive Bladder (OASIS - Overactive Bladder Stimulation System Study)
Aims: This study will evaluate the efficacy and safety of the BlueWind RENOVA iStim system, which is an implantable tibial nerve stimulator that can be used at home for patients with urgency incontinence or both urgency incontinence and urinary urgency and/or urinary frequency. 
Diagnosis: Females ages 21 or older with a diagnosis of overactive bladder (OAB) or urinary urge incontinence (UUI) for at least 6 months
Principal Investigator: Ghazaleh Rostami Nia, MD
IRB Approval Number: EH21-120
Sponsor: BlueWind Medical
Contact: Interested patients should call 224.251.3492 
Open to Enrollment: Yes

Pivotal Study of Subcutaneous Tibial Nerve Stimulation with eCoin for Urgency Urinary Incontinence
Aims: This study will evaluate the efficacy and safety of the Valencia Technologies eCoin to be incorporated in a Pre-Market Approval application. The eCoin (electroceutical coni) device is an investigational device to be used in the treatment of patients with overactive bladder (OAB) and associated symptoms of urinary urgency, urinary frequency, and urinary urge incontinence.
Diagnosis: Women ages 18-80 with a diagnosis of OAB with urge urinary incontinence or mixed urge and stress incontinence for at least 6 months
Principal Investigator: Peter Sand, MD
Co-Investigator(s): Roger Goldberg, MD; Adam Gafni-Kane, MD; Sonia Dutta, MD
IRB Approval Number: EH18-138
Sponsor: Valencia Technologies
Contact: Interested patients should call 224.251.3492
Open to Enrollment: No